KNSA
KINIKSA PHARMA (KNSA)
NASDAQ
$59.39+$2.26 (+3.96%)
Price as of Jun 23, 2026 4:59 PM EDT
  • $2.4B
    Market Cap
  • 98.92%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 72
Valuation
KNSA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 61
Valuation
KNSA
vs History
vs S&P 500
3-Month Momentum
20.22%
12-Month Momentum
90.86%
3-Month Risk Adjusted Momentum
72.75%
12-Month Risk Adjusted Momentum
217.30%

True Yield

N/A
Valuation
KNSA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 87
Valuation
KNSA
vs History
vs S&P 500
Ohlson's O-Score
10